Is Prazosin Dialyzable?
No, prazosin is not dialyzable because it is highly protein bound (92-97%), which prevents effective removal by hemodialysis. 1
Primary Evidence from FDA Labeling
The FDA drug label explicitly states that "prazosin hydrochloride is not dialyzable because it is protein bound." 1 This is the definitive answer based on the highest-priority evidence source.
Pharmacokinetic Basis for Non-Dialyzability
The pharmacokinetic properties of prazosin explain why dialysis is ineffective:
Extensive protein binding: Prazosin is 92-97% bound to plasma proteins (albumin and alpha-1-acid glycoprotein), which is independent of plasma concentration in the therapeutic range. 2
Large volume of distribution: The steady-state volume of distribution is 42.2 ± 8.9L, indicating extensive tissue distribution beyond the plasma compartment. 2
Hepatic metabolism predominates: Prazosin undergoes extensive first-pass metabolism by the liver, with only 6% excreted unchanged (mainly in urine), while the two main metabolites are almost completely excreted in bile. 2
Clinical Implications
In Overdose Management
If prazosin overdose leads to hypotension, dialysis should not be considered as a treatment modality. 1 Instead, management should focus on:
- Keeping the patient supine to restore blood pressure 1
- Volume expanders as first-line shock treatment 1
- Vasopressors if volume expansion is inadequate 1
- Monitoring and supporting renal function 1
In Renal Failure Patients
Prazosin can be safely used in patients with impaired renal function without dose adjustment based on dialysis status:
- Elimination kinetics are virtually identical regardless of degree of renal function 3
- No drug accumulation occurs with repeated dosing in renal impairment 3
- The elimination half-life may be prolonged in chronic renal failure, but this is due to altered protein binding and pharmacodynamics, not dialyzability 2
- Prazosin is effective for hypertension control in hemodialysis patients at doses of 5-40 mg daily, either alone or with additional antihypertensives 4
Dosing Considerations
While prazosin is not removed by dialysis, dosage should still be titrated cautiously in patients with chronic renal failure due to increased plasma free fraction and prolonged elimination half-life from altered protein binding. 2